pharmaphorum22h
EU approves CSL's once-monthly HAE drug Andembry
CSL has been given approval by the European Commission for Andembry, the first once-monthly preventive therapy for the ...
PMLiVE23h
EC approves CSL’s Andembry to prevent hereditary angioedema attacks
The European Commission (EC) has approved CSL’s Andembry (garadacimab) to prevent attacks of hereditary angioedema (HAE) in ...
GlobalData on MSN20h
EC approves CSL’s Andembry to stop hereditary angioedema attacks
CSL has received approval from the European Commission (EC) for Andembry (garadacimab) to prevent recurrent attacks of ...
News Medical23h
Evaluating influenza vaccine ingredients
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...